PRESS RELEASE

Munich, 12 December 2023

honert provided comprehensive legal and tax advice to Aristo Pharma GmbH on a seed investment in VaRi Bioscience GmbH.

Aristo Pharma GmbH, headquartered in Berlin, employs around 1,700 people at five different production sites in Germany and Spain and focuses on the manufacture and distribution of generics.

VaRi Bioscience GmbH is an innovative German biotech company from Berlin-Brandenburg that is doing pioneering work in the field of female health.

The Advisors:

honert (Munich): Dr. Kai-Klemens Wehlage (lead, venture capital, corporate law), Sven Fritsche (venture capital, tax), Peter Kipp und Veronika Nößner (both venture capital).